Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Nivolumab 27 pembrolizumab 22 Ipilimumab 17 Temozolomide 13 toripalimab 12 Biopsy 10 Cyclophosphamide 9 Imiquimod 8 Dacarbazine 7 Blood Specimen Collection 7 camrelizumab 6 Chemotherapy, Adjuvant 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 aldesleukin 5 Gene Expression Profiling 5 Cisplatin 5 Aminolevulinic Acid 5 fludarabine phosphate 4 durvalumab 4 binimetinib 4 apatinib 4 Tomography, Optical Coherence 4 Sorafenib 4 Photochemotherapy 4 Interleukin-2 4 Injections 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Toll-Like Receptor 1 × Dermatologic × Clear all

NCT03374839 2022-05-06

Nivo-TIL

Nantes University Hospital

Phase 1/2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡